These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25975105)

  • 1. [Cytoflavin® effect on endothelium function and cerebral hemodynamics in patients with hypertensive enceplalopathy].
    Belova LA; Mashin VV; Kolotik-Kameneva OY; Proshin AN
    Antibiot Khimioter; 2014; 59(7-8):30-6. PubMed ID: 25975105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The influence of Cytoflavin therapy on the cerebral hemodynamics in patients with various stages of hypertensive disease].
    Belova LA; Mashin VV; Kolotik-Kameneva OY; Belova NV; Scuderi A; Antignani PL
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(7):28-35. PubMed ID: 28805757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The influence of citoflavin on molecular mechanisms of hypertensive encephalopathy development in patients with systolic arterial hypertension].
    Kartashova EA; Romantsov MG; Sarvilina IV
    Eksp Klin Farmakol; 2014; 77(6):18-23. PubMed ID: 25102730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cytoflavin and neuronol on morphological changes in the brain and survival of rats with ischemic disturbances in cerebral blood flow.
    Bul'on VV; Krylova IB; Evdokimova NR; Kovalenko AL; Alekseeva LE; Sapronov NS
    Bull Exp Biol Med; 2004 Apr; 137(4):411-4. PubMed ID: 15452617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [THE PHARMACOTHERAPEUTIC EFFICIENCY OF CYTOFLAVIN IN PATIENTS WITH DIABETIC FOOT SYNDROME: IMMEDIATE AND LONG-TERM RESULTS].
    Markevich PS; Markevich LB; Plekhanov AN; Kovalenko AL
    Klin Med (Mosk); 2015; 93(6):67-72. PubMed ID: 26495531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of the energy-modifier cytoflavin in the treatment of patients with hypertensive encephalopathy].
    Belova LA; Kolotik-Kameneva OIu; Mashin VV; Saprygina LV; Mashin EV
    Ter Arkh; 2014; 86(9):65-70. PubMed ID: 25518508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of cytoflavin on the clinical and autonomic-psychological manifestations of hypertensive disease].
    Belova LA; Mashin VV; Kolotik-Kameneva OY; Belova NV
    Ter Arkh; 2016; 88(5):55-61. PubMed ID: 27239928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dynamics of indicators of the functional state of the central nervous system in Navy operators treated with cytoflavin after a long working cycle].
    Parfenov SA; Belov VG; Parfenov YA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(8):55-58. PubMed ID: 28884718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of multimodal effect of cytoflavin in the acute brain stroke in patients with metabolic syndrome].
    Muratov FK; Shermukhamedova FK; Batocyrenov BV; Haritonova TV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(12):44-47. PubMed ID: 28139625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [STRESS-PROTECTIVE EFFECT OF CYTOFLAVIN ON CHRONIC CEREBRAL ISCHEMIA IN RATS.].
    Krylov VN; Deryugina AV; Antipenko EA
    Eksp Klin Farmakol; 2016; 79(9):29-32. PubMed ID: 29787669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of cytoflavin in sports nutrition].
    Kosinets VA; Stolbitskiĭ VV; Shturich IP
    Klin Med (Mosk); 2012; 90(7):56-8. PubMed ID: 23019978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of cytoflavin in patients with hypertonic encephalopathy and constitutional venous insufficiency].
    Belova LA; Mashin VV; Kolotik-Kameneva OIu; Belova NV; Byrina AV; Evstigneeva AIu; Abramova VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(8):21-6. PubMed ID: 23096033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative experimental study of the influence of drugs that improve brain metabolism (angiogen, cytoflavin) on neuronal apoptosis and function of cerebral cortex during aging].
    Bazhanova ED; Anisimov VN; Sukhanov DS; Teplyĭ DL
    Eksp Klin Farmakol; 2015; 78(2):3-9. PubMed ID: 25898540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Protective effect of cytoflavin and its components in mice with acute alloxan intoxication].
    Volchegorskiĭ IA; Rassokhina LM; Ermakova SG; Miroshnichenko IIu
    Eksp Klin Farmakol; 2013; 76(4):26-31. PubMed ID: 23762986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of bio-inverse communication and Cytoflavin effects on the dynamics of the clinical and psychophysiological condition of elderly patients with osteochondrosis].
    Belov VG; Parfenov YA; Vasilevskaya MA; Parfenov SA; Kovalenko AL; Zaplutanov VA
    Adv Gerontol; 2017; 30(4):601-608. PubMed ID: 28968038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The intraoperative prophylaxis of local ischemical brain damage in neurosurgical patients with cerebral aneurysm].
    Savvina IA; Cherebillo VY; Zabrodskaya YM; Petrova AO; Sergeev AV; Paltsev AA; Rutkovskiy RV; Malkhozova AM
    Khirurgiia (Mosk); 2019; (5):57-63. PubMed ID: 31169820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antioxidant and membranoprotector treatment of chronic pyelonephritis].
    Gordiushina IV; Savchenko RP; Sukhanov DS; Petrov AIu; Romantsov MG
    Eksp Klin Farmakol; 2011; 74(4):27-30. PubMed ID: 21678656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Using cytoflavin for correcting x-ray contrasting agent-induced nephropathy].
    Karpishchenko SN; Zheregelia SN; Glushkov SI
    Eksp Klin Farmakol; 2010 Oct; 73(10):40-2. PubMed ID: 21254514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Substantiation of the drug «Cytoflavin» application and cognitive-behavioral therapy in complex treatment of deforming coxarthrosis in elderly patients.].
    Zakharov IK; Belov VG; Parfyonov UA; Parfyonov SA; Ershov EV; Sapozhnikov KV; Zaplutanov VA
    Adv Gerontol; 2019; 32(3):439-444. PubMed ID: 31512432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The study of the effectiveness of drug prevention mechanisms of cardiovascular aging by cytoflavin].
    Kartashova EA; Romantsov MG; Sarvilina IV
    Adv Gerontol; 2014; 27(4):737-45. PubMed ID: 25946853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.